Infectious Disease

Bacterial, viral, and fungal diseases represent a significant global health challenge, and innovative therapeutics have the potential to significantly improve treatment options for patients afflicted with infectious disease. These illnesses are often life-threatening, leading to the deaths of millions of individuals worldwide every year. The Momentum team is proud to support the creation of next-generation antibiotics, antivirals, and antifungals through a wide range of screening and proteomic services. Thanks to our well-established workflows, we can provide high-quality data with rapid turnaround times, advancing drug discovery and development.

Our target deconvolution and selectivity technologies (TargetScout™, CysScout™, PhotoTargetScout™, and SideScout™) are particularly valuable for the interrogation of drug targets and mechanisms across diverse infectious indications. By integrating our technical expertise and assay development capabilities into your infectious disease research, you can accelerate preclinical development and bring potent therapeutics into the clinic faster than ever.

Services to support Infectious Disease research:

TargetScout™
CysScout™
PhotoTargetScout™
SideScout™

Explore Other Therapeutic Areas

Support for the development of novel treatments for a range of diseases

Rare Diseases
Accelerate the development of rare disease treatments
I/O
Harness immunological knowledge for next-generation cancer treatments
Chronic Diseases
Unlock novel treatment options for chronic disease conditions
Oncology
Support for the development of cutting-edge cancer therapeutics
Immunology
Leverage system-wide insights to advance immunology and inflammation research
Neuroscience
Advance treatment options for neurological conditions and beyond
Metabolic Disease
Develop therapeutics for diabetes, obesity, and other metabolic disorders